Sclerotherapy vs. esophageal transection
โ
Seigo Kitano; Yasunori Iso; Makoto Hashizume; Hirohiko Yamaga; Nobuhiro Koyanagi
๐
Article
๐
1992
๐
John Wiley and Sons
๐
English
โ 691 KB
Ninety-six patients with good liver function (Child class A or B) and esophageal varices were randomly assigned to one of three groups given different treatments: endoscopic injection sclerotherapy (n = 32), esophageal transection (n = 32) or distal splenorenal shunt (n = 32). Five patients (5.2%) h